National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
   
 
Results: 1 -7 of 7         results per page
View Search Criteria | Help With Results
           

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II, Phase I


Treatment


Active


18 and over


Other


H06-128
IND78,248, NCT00707252


2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Biomarker/Laboratory analysis, Treatment


Active


18 and over


Other


Dietary intervention FL
NCT00455416


3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Prevention


Active


30 to 80


NCI, Other


MCC 15008
USF#105730, NCT00596011


4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Biomarker/Laboratory analysis, Treatment


Active


21 to 75


Other


H04-179
NCT00676793


5.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Biomarker/Laboratory analysis, Diagnostic, Treatment


Active


18 and over


Other


07-0580-B
NCT00744549

Last Modified: 4/10/2008     First Published: 8/10/2007  

6.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Biomarker/Laboratory analysis, Prevention, Treatment


Active


21 to 65


NCI


MDA-MDA04-4-01
MDA04-4-01, NCT00516243, MDA-2006-0521, CPMC-IRB-AAAB7638

Last Modified: 7/30/2008     First Published: 11/4/2005  

7.

Phase
Type
Status
Age
Sponsor
Protocol IDs

No phase specified


Prevention


Active


18 and over


NCI


OHSU-CI-CPC-04131-LX
VAMC-04-0303, DOD-A-12538, OHSU-1117, OHSU-KPNW-NW-05SLIEB-01, NCT00253643

   
   

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov